
bypass grafting.
The relationship between volume and outcomes has
been explored for TEVAR,218-220 and the data supporting
or refuting such a relationship are poor, mainly because
these studies are typically underpowered and the data
are heterogeneous, including EVAR and TEVAR, or
TEVAR when used to treat multiple pathologic processes
(ie, aneurysm and dissection). One study using the Medicare claims database from 199